Arunachal Pradesh launches HPV vaccination drive to protect girls from cervical cancer
Arunachal Pradesh has commenced an HPV vaccination drive targeting girls aged 14-15 to prevent cervical cancer, aligning with a nationwide initiative launched by Prime Minister Narendra Modi. The program aims to vaccinate approximately 19,500 girls in its initial phase within three months, utilizing the state's existing health infrastructure.
Key Highlights
- HPV vaccination drive initiated in Arunachal Pradesh for girls aged 14-15.
- The drive is part of a nationwide campaign launched by PM Narendra Modi.
- Objective is to prevent cervical cancer, a significant health concern in India.
- Arunachal Pradesh aims to vaccinate around 19,500 girls in the first phase.
- The campaign will be conducted over three months using state health facilities.
- Vaccination is free and voluntary, with parental consent required.
Arunachal Pradesh has officially launched a Human Papillomavirus (HPV) vaccination drive aimed at protecting adolescent girls from cervical cancer, a move that aligns with the nationwide initiative spearheaded by Prime Minister Narendra Modi.. The program, which commenced following the national rollout on February 28, 2026, focuses on girls in the 14-15 years age group, recognizing the critical window for preventing HPV infections that can lead to cervical cancer..
In Arunachal Pradesh, the state government has set a target of vaccinating approximately 19,500 girls in its initial phase, with the aim of completing this coverage within three months.. The vaccination will be administered free of cost at designated government health facilities, including Primary Health Centres (PHCs), Community Health Centres (CHCs), District Hospitals, and the Tomo Riba Institute of Health & Medical Sciences (TRIHMS).. This initiative is part of a larger national campaign that aims to vaccinate around 1.15 crore girls aged 14 years annually across all states and Union Territories..
Cervical cancer is a significant public health challenge in India, being the second most common cancer among women.. GLOBOCAN 2022 data indicates over 1,20,000 new cases and nearly 80,000 deaths annually in India, with the country accounting for approximately 25% of global cervical cancer deaths.. The Human Papillomavirus (HPV) is responsible for nearly 99.7% of cervical cancer cases in India, making vaccination a powerful preventive tool.. The HPV vaccine, specifically Gardasil-4, a quadrivalent vaccine, protects against HPV types 16 and 18, which are the primary causes of cervical cancer, as well as types 6 and 11 associated with genital warts..
The nationwide campaign, launched on February 28, 2026, emphasizes a single-dose regimen for adolescents, which has been shown to be highly effective, simplifying logistics and improving compliance.. This aligns with the World Health Organization's (WHO) recommendation for a simplified schedule, especially for younger age groups.. The vaccination is voluntary, and informed consent from parents or guardians is a prerequisite for administration..
Arunachal Pradesh Chief Minister Pema Khandu, along with Health Minister Biyuram Wahge, launched the state-level drive, emphasizing the vaccine's safety and its critical role in preventing HPV-related cancers.. Khandu highlighted that the vaccine is safe, citing global administration of over 50 crore doses and his own daughter having received it.. The state's health infrastructure is being leveraged to ensure the campaign's success, with coordination efforts involving the Education Department to raise awareness in schools..
This initiative by Arunachal Pradesh is part of a broader national commitment to eliminate cervical cancer, a goal that aligns with the WHO's '90-70-90' targets for vaccination, screening, and treatment by 2030.. The inclusion of HPV vaccination in the national immunization schedule marks a significant step in India's public health journey, aiming to safeguard the health and future of millions of young girls across the country.. The program's success hinges on community participation, awareness, and continued collaboration among healthcare providers, schools, parents, and policymakers..
Meanwhile, other states like Madhya Pradesh and cities like Pune have also commenced their own HPV vaccination drives as part of the nationwide effort. Madhya Pradesh Chief Minister Mohan Yadav highlighted the free provision of the Gardasil vaccine, which typically costs around Rs 9,000 in private clinics, emphasizing the government's commitment to women's health.. Pune Municipal Corporation (PMC) is also actively participating, becoming one of the first civic bodies to implement such an initiative at the local level, offering free HPV vaccines through CSR support.. These localized efforts, while varying slightly in their specific age targets or implementation details, collectively contribute to the overarching national goal of cervical cancer prevention..
Frequently Asked Questions
What is the HPV vaccine and why is it being administered?
The HPV (Human Papillomavirus) vaccine is administered to prevent infections caused by the Human Papillomavirus, which is the primary cause of cervical cancer. It is also effective against other HPV-related cancers and genital warts. The vaccination is a crucial preventive measure against cervical cancer, which is a significant health concern in India.
Who is eligible for the HPV vaccine in this drive?
In Arunachal Pradesh, as part of the nationwide campaign, the HPV vaccine is being administered to girls aged 14-15 years. The national program generally targets 14-year-old girls, with some variations in age eligibility across different local initiatives.
Is the HPV vaccine safe and effective?
Yes, the HPV vaccine is considered safe and highly effective. It has been administered globally to millions of individuals and is a key tool in preventing HPV infections and related cancers. Public health officials and state leaders have reassured the public about the vaccine's safety.